|
DepoCyt Therapy in Patients with Neoplastic Meningitis from Lymphoma or a Solid Tumor Clinical Trials Information presented on Clinical Trials Search is not designed to be a substitute for proven healthcare advice, travels to or treatment by using a genuine medical doctor. We are not physicians. Always confer with your doctor on DepoCyt Therapy in Patients with Neoplastic Meningitis from Lymphoma or a Solid Tumor conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. DepoCyt Therapy in Patients with Neoplastic Meningitis from Lymphoma or a Solid Tumor Clinical research trials and DepoCyt Therapy in Patients with Neoplastic Meningitis from Lymphoma or a Solid Tumor healthcare trials take place in many of cities across the United States of America. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally evaluate the effectiveness of new drugs. The function of the studies / undertakings is to answer specific human medical questions. Clinical trials are a popular means for mDs, government agencies, and private sector companies to find treatments for all forms of conditions, including DepoCyt Therapy in Patients with Neoplastic Meningitis from Lymphoma or a Solid Tumor. DepoCyt Therapy in Patients with Neoplastic Meningitis from Lymphoma or a Solid Tumor Clinical Trials and other clinical trials allow for volunteers to access medical treatment alternatives before they are available to the masses. Many times the test subjects undergo treatment for without cost, and occasionally they are compensated for their time. Occasionally there is a cost for a DepoCyt Therapy in Patients with Neoplastic Meningitis from Lymphoma or a Solid Tumor clinical trial. Test subjects oftentimes recieve the best healthcare possible for their DepoCyt Therapy in Patients with Neoplastic Meningitis from Lymphoma or a Solid Tumor condition. Hazards are a reality, nonetheless, and might include additional or frequent doctor trips, healthcare hazards (perhaps life-jeopardizing), and/or the treatment being ineffective. Trials are federally regulated with rigid guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "D" Clinical Trials Conditions > DepoCyt Therapy in Patients with Neoplastic Meningitis from Lymphoma or a Solid Tumor  DepoCyt Therapy in Patients with Neoplastic Meningitis from Lymphoma or a Solid Tumor
DepoCyt Therapy in Patients with Neoplastic Meningitis from Lymphoma or a Solid Tumor
For Condition: Meningeal Neoplasms
Status: Recruiting
Sponsor(s): SkyePharma ,
Synopsis: The purpose of this study is to find out how well an experimental drug called DepoCyt works for neoplastic meningitis (cancer that has spread to the tissues around the brain and spinal cord). DepoCyt is a new slow-release form of the cancer drug called ara-C (cytarabine). Cytarabine has been used for many years to treat cancer.
Details:
Eligibility:
Study Type: Interventional, Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: Diagnosed (or previously diagnosed) with lymphoma or a solid tumor (not leukemia) Diagnosed with neoplastic meningitis If female, not pregnant and will not become pregnant while on-study No other experimental therapy within 21 days of participation
Total Enrollment: 100
Location and Contact Information:
Overall Study Official:
JohnGait, , Director, Pharmacovigilance and Medical Affairs / DepoCyt Medical Monitor
University of Texas Health Science Center *Recruiting*
San Antonio, Texas, 78284
United States
Recruiting Diane Johnson 210-617-5300
Case Western Reserve University Hospital of Cleveland *Recruiting*
Cleveland, Ohio, 44106
United States
Recruiting Joan Kolb 216-844-7792
Georgetown University Medical Center Hematology/Oncology *Recruiting*
Washington D.C., District of Columbia, 20007
United States
Recruiting Said Baidas 202-687-7320
University of Pittsburgh Cancer Institute *Not yet recruiting*
Pittsburgh, Pennsylvania, 15213
United States
Not yet recruiting Frank Lieberman 412-692-2600
Barrow Neurological Institute *Recruiting*
Phoenix, Arizona, 85013
United States
Recruiting Emily Khoury 602-406-3614
Bowman Gray School of Medicine/Comprehensive Cancer Center of Wake Forest University *Recruiting*
Winston Salem, North Carolina, 27157
United States
Recruiting Michele Harmon 336-716-1193
JFK Neuroscience Institute *Recruiting*
Edison, New Jersey, 08820
United States
Recruiting Susan Fowler 732-632-1584
Rush Cancer Institute *Recruiting*
Chicago, Illinois, 60612
United States
Recruiting Allan Taaca 312-942-5687
University of Southern California, Norris Cancer Center *Not yet recruiting*
Los Angeles, California, 90033
United States
Not yet recruiting Traci Babcock 323-865-3945
Straub Clinic and Hospital *Not yet recruiting*
Honolulu, Hawaii, 96813
United States
Not yet recruiting Carroll Mimaki 808-780-6561
University of Colorado Hospital, Anschutz Cancer Pavilion *Recruiting*
Denver, Colorado, 80010
United States
Recruiting Lisa Robinson 720-848-0667
Park Nicollet Institute, Oncology Research Program *Recruiting*
Minneapolis, Minnesota, 55416
United States
Recruiting Janet Hagen 952-993-6705
Loyola University Medical Center, Dept. of Hematology/Oncology *Not yet recruiting*
Maywood, Illinois, 60153
United States
Not yet recruiting Lode Swinnen 708-327-3142
Virginia Mason Medical Center *Recruiting*
Seattle, Washington, 98101
United States
Recruiting Cheryl Clark-Weaver 206-223-6748
Emory Clinic, Department of Neurosurgery *Not yet recruiting*
Atlanta, Georgia, 30322
United States
Not yet recruiting Carol Hill 404-778-4907
Alta Bates Comprehensive Cancer Center *Not yet recruiting*
Berkeley, California, 94704
United States
Not yet recruiting Beth Davis 510-204-3428
Toronto Sunnybrook Regional Cancer Center *Recruiting*
Toronto, Ontario, M4N3M5
Canada
Recruiting Cindy Foden 416-480-5846
Mayo Clinic, Jacksonville *Recruiting*
Jacksonville, Florida, 32224
United States
Recruiting Carolyn Bieber 904-953-6824
Beth Israel Deaconess Medical Center Dept. of Neurology *Recruiting*
Boston, Massachusetts, 02215
United States
Recruiting Loretta Barron 617-667-1665
University of Utah, Hunsman Cancer Institute *Recruiting*
Salt Lake City, Utah, 84112
United States
Recruiting Julia Batten 801-585-6456
H. Lee Moffitt Cancer Center and Research Institute *Recruiting*
Tampa, Florida, 33612
United States
Recruiting Shirley Entis 813-979-3951
CancerCare Manitoba *Not yet recruiting*
Winnipeg, Manitoba, R3E0V9
Canada
Not yet recruiting Erna Stiles 204-787-2127
Vanderbilt University Medical Center *Not yet recruiting*
Nashville, Tennessee, 37232
United States
Not yet recruiting Paul Moots 615-936-0216
Additional Information:
Study ID Numbers: SKY0101-010;
Study Start Date: April 2001
Record last reviewed: January 2002
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00029523
Other Meningeal Neoplasms Studies:
1. Phase I Study of Intrathecal Topotecan
2. DepoCyt Therapy in Patients with Neoplastic Meningitis from Lymphoma or a Solid Tumor
3. Phase I Study of Gemcitabine to Treat Cancer Spread to the Meninges
Related Studies:
Other Meningeal Neoplasms Clinical Trials
Other Manitoba Clinical Trials
Other Winnipeg Clinical Trials
DepoCyt Therapy in Patients with Neoplastic Meningitis from Lymphoma or a Solid Tumor
|
|
|
|
|
|
|
|
